JMEE Among Mid Cap ETFs
End-of-day Nov 16, 2026 · 93 Mid cap ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.4% | −2.2% | +0.3% | −6.0% | +14.4% | +18.6% | +62.1% | — | +67.6% |
| Peer average | −1.3% | −1.8% | +0.6% | −4.5% | +11.2% | +14.9% | +60.6% | +36.1% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$8 of every $1,000 in JMEE is United
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | —Jpmorgan Prime Money | — | 4.56% | $455.70 | 133.8M | $133.8M |
| 2 | UTHRUnited Therapeutics | Healthcare | 0.76% | $76.33 | 38K | $22.4M |
| 3 | FTITechnipfmc | Energy | 0.61% | $60.65 | 269K | $17.8M |
| 4 | RSReliance | Basic Materials | 0.52% | $52.43 | 36K | $15.4M |
| 5 | NVTNvent Electric | Industrials | 0.51% | $50.98 | 131K | $15.0M |
| 6 | CWCurtiss-wright | Industrials | 0.47% | $46.61 | 29K | $13.7M |
| 7 | WTSWatts Water Technologies | Industrials | 0.47% | $46.58 | 38K | $13.7M |
| 8 | ATIATI | Industrials | 0.46% | $45.89 | 74K | $13.5M |
| 9 | JAZZJAZZ Pharmaceuticals | Healthcare | 0.45% | $44.91 | 55K | $13.2M |
| 10 | THCTenet Healthcare | Healthcare | 0.45% | $44.89 | 46K | $13.2M |
| 11 | HALOHalozyme Therapeutics | Healthcare | 0.44% | $43.96 | 129K | $12.9M |
| 12 | PNFPPinnacle Financial | Financial Services | 0.44% | $43.55 | 127K | $12.8M |
| 13 | WWDWoodward | Industrials | 0.44% | $43.51 | 39K | $12.8M |
| 14 | GKOSGlaukos | Healthcare | 0.42% | $42.47 | 51K | $12.5M |
| 15 | JLLJones Lang Lasalle | Real Estate | 0.42% | $42.31 | 34K | $12.4M |
of the $525B in 108 Mid cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | UTHR | United Therapeutics | 0.76% |
| 2 | FTI | Technipfmc | 0.61% |
| 3 | RS | Reliance | 0.52% |
| 4 | NVT | Nvent Electric | 0.51% |
| 5 | CW | Curtiss-wright | 0.47% |
| 6 | WTS | Watts Water Technologies | 0.47% |
| 7 | ATI | ATI | 0.46% |
| 8 | JAZZ | JAZZ Pharmaceuticals | 0.45% |
| 9 | THC | Tenet Healthcare | 0.45% |
| 10 | HALO | Halozyme Therapeutics | 0.44% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 16, 2025 | Dec 18, 2025 | $0.72 |
| Dec 24, 2024 | Dec 27, 2024 | $0.57 |
| Dec 19, 2023 | Dec 22, 2023 | $0.67 |
| Dec 20, 2022 | Dec 23, 2022 | $0.66 |